NEW YORK (GenomeWeb) - Affymetrix today reported a slight decrease year over year in its third quarter reported revenues.

For the three months ended Sept. 30, Affymetrix's total revenues dipped less than one percent to $86.5 million from $87.1 million in the prior-year period. On a constant currency basis, its revenues increased almost 4 percent year over year, and beat the average Wall Street estimate of $87.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.